Delineating the role of adenosine monophosphate (AMP)-activated protein kinase (AMP) gamma 2 subunit in hypertrophic cardiomyopathy (HCM)

Eitemau Tebyg

• Novel mutations in cardiac MYPBC3 cause early onset malignant hypertrophic cardiomyopathy (HCM)
  gan: Carballo, S, et al.
  Cyhoeddwyd: (2005)
• Hypertrophic cardiomyopathy mutations in the gamma 2 subunit of AMP-activated kinase suggest a central role of energy compromise in disease pathogenesis
  gan: Blair, E, et al.
  Cyhoeddwyd: (2001)
• Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis.
  gan: Blair, E, et al.
  Cyhoeddwyd: (2001)
• Mutations in the gamma2 subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis.
  gan: Blair, E, et al.
  Cyhoeddwyd: (2001)
• Mutation analysis of genes encoding subunits of AMP-activated protein kinase (AMPK) in inherited cardiomyopathies
  gan: Blair, E, et al.
  Cyhoeddwyd: (2002)